Screening

Screening

Who Should Be Screened for H. pylori?

Screening for Helicobacter pylori (H. pylori) is crucial for individuals at higher risk of developing complications, such as peptic ulcers, chronic gastritis, and gastric cancer. While routine screening is not recommended for the general population, it is strongly advised for specific high-risk groups to ensure early detection and treatment.

​

High-Risk Groups for H. pylori Screening
​
1. Individuals with a History of Peptic Ulcers

Anyone with active or recurrent peptic ulcers (gastric or duodenal ulcers) should be screened.

H. pylori infection is a major cause of ulcers, and eradication significantly reduces the risk of recurrence.

​

2. People with Unexplained, Persistent Dyspepsia (Indigestion)

Chronic indigestion, bloating, nausea, or upper abdominal pain without an obvious cause may indicate H. pylori-related gastritis.

Screening is especially important for individuals who experience symptoms for more than four weeks and do not respond to standard acid-reducing medications.

​

3. Individuals with a Family History of Gastric Cancer

A strong family history of stomach cancer increases the risk of developing H. pylori-associated gastric malignancies.

Early detection and eradication of H. pylori can lower the risk of gastric cancer in these individuals.

​

4. People from Regions with a High Prevalence of Gastric Cancer

Certain parts of the world, including East Asia, Eastern Europe, and some regions in Latin America and Africa, have higher rates of H. pylori infection and stomach cancer.

Individuals from these regions, particularly if they experience gastrointestinal symptoms, should consider screening.

 

5. Patients Before Starting Long-Term NSAID or Aspirin Therapy

Nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin can weaken the stomach lining, increasing the risk of ulcers.

Screening and treating H. pylori before starting long-term NSAID therapy can reduce ulcer risk in these patients.

 

6. Patients with Unexplained Iron-Deficiency Anemia

H. pylori infection has been linked to chronic iron deficiency anemia, even in the absence of ulcers.

Screening is recommended for patients with persistent anemia that does not respond to iron supplementation.

 

7. Individuals with Immune Thrombocytopenic Purpura (ITP)

H. pylori infection has been associated with ITP, a condition that causes a low platelet count.

Eradicating H. pylori has been shown to improve platelet levels in some patients.

​

Screening Methods for H. pylori

The most common and reliable non-invasive tests for detecting H. pylori include:

​

  1. Urea Breath Test

    • The patient drinks a harmless radioactive or non-radioactive solution. If H. pylori is present, the bacteria break down the solution, releasing carbon dioxide that can be detected in the breath.

    • Highly accurate and preferred for initial diagnosis & post-treatment follow-up.

  2. Stool Antigen Test

    • Detects H. pylori antigens (proteins) in a stool sample.

    • Useful for both diagnosis and confirming eradication after treatment.

  3. Blood Antibody Test (Less commonly used)

    • Detects antibodies against H. pylori in the blood.

    • Not ideal for confirming active infection, as antibodies may remain present even after the bacteria are eradicated.

  4. Endoscopy with Biopsy (For high-risk cases)

    • A small camera (endoscope) is inserted into the stomach, and a tissue sample (biopsy) is taken for testing.

    • Recommended for patients with ulcers, unexplained weight loss, gastrointestinal bleeding, or suspected gastric cancer.

​

Why Screening Matters

  • Early detection prevents complications such as ulcers, stomach bleeding, and cancer

  • Timely treatment improves symptoms and reduces transmission to others.

  • Screening high-risk individuals ensures targeted and effective intervention, rather than unnecessary testing for the general population.